Yunnan Chuxiong Tianli Pharmaceutical

Yunnan Chuxiong Tianli Pharmaceutical is a specialized pharmaceutical manufacturer based in Chuxiong, Yunnan Province, China. Founded in 1994, the company focuses on the development and production of modern Traditional Chinese Medicine (TCM) and botanical-based pharmaceuticals, particularly those derived from the local medicinal plant Erigeron breviscapus (Dengzhanhua). Its core product portfolio includes treatments for cardiovascular and cerebrovascular diseases, such as Scutellarin injections and tablets. The company operates multiple GMP-certified production lines and is recognized as a high-tech enterprise within the Yunnan regional pharmaceutical industry. Tianli Pharmaceutical plays a key role in the industrialization of Yunnan's botanical resources for chronic disease management.